Compare Medpace Holdings Inc (MEDP) vs Vanguard Information Technology Index Fund ETF (VGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Vanguard Information Technology Index Fund ETF — how do they compare? Medpace Holdings Inc trades at $528.16 (market cap $15.18B), while Vanguard Information Technology Index Fund ETF trades at $115.76. The key difference: Vanguard Information Technology Index Fund ETF is trading nearer its 52-week high, Medpace Holdings Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | VGT | |
|---|---|---|
Market Cap | $15.18B | — |
Sector | Technology | — |
52-Week High | $620.59 | $125.77 |
52-Week Low | $393.42 | $83.59 |
Enterprise Value | $14.65B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% on the day, with a neutral technical signal and mixed oscillators. The stock shows strong profitability with a 17.19% net margin and 77.25% ROE, though valuations are elevated with a P/E of 33.22. Recent quarters have consistently beaten EPS estimates, but a class action lawsuit filed in June 2026 adds uncertainty. Revenue is projected to grow to $2.7B in 2026, while cash flow trends improve from negative to positive net cash flow.
The outlook is cautious due to high valuation and legal overhangs, but fundamental strength in earnings and backlog quality provides support. Analyst consensus is mixed with a $497 price target below current levels, indicating limited near-term upside. Key risks include lawsuit outcomes and competitive pressures in the CRO sector.
VGT trades at $113.23, showing minimal daily movement with a 0.11% gain. Technical indicators signal bearish momentum with moving averages and ADX pointing downward, though RSI suggests potential oversold conditions near support at $113. Recent news highlights strong long-term performance with 25% average annual returns over 10 years, while current market focus centers on semiconductor sector volatility and AI-driven growth prospects.
The ETF's outlook remains positive for long-term investors despite near-term technical weakness, with technology sector dominance and AI exposure providing growth catalysts. Key risks include semiconductor concentration, valuation concerns after recent run-ups, and broader market volatility. Wall Street maintains constructive views on tech sector leadership through 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →
